Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.
about
Fundamentals of aerosol therapy in critical careNatural Bizbenzoquinoline Derivatives Protect Zebrafish Lateral Line Sensory Hair Cells from Aminoglycoside ToxicityTobramycin inhalation powder (TOBI Podhaler) for the treatment of lung infection in patients with cystic fibrosis.Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis.Quinoxaline protects zebrafish lateral line hair cells from cisplatin and aminoglycosides damage
P2860
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.
@en
type
label
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.
@en
prefLabel
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.
@en
P2093
P2860
P356
P1476
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis.
@en
P2093
Carolina Cisneros
Claudia Valenzuela
Elena García-Castillo
Emma Vázquez-Espinosa
Enrique Zamora
F Javier García-Pérez
Julio Ancochea
Rosa Mar Gómez-Punter
Rosa María Girón
P2860
P304
P356
10.2147/TCRM.S75208
P577
2015-03-12T00:00:00Z